|
G |
Abat |
4-aminobutyrate aminotransferase |
increases response to substance |
ISO |
ABAT mRNA results in increased susceptibility to Pentylenetetrazole |
CTD |
PMID:10850552 |
|
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
|
|
G |
Ache |
acetylcholinesterase |
increases activity multiple interactions |
EXP |
Pentylenetetrazole results in increased activity of ACHE protein Vitamin U inhibits the reaction [Pentylenetetrazole results in increased activity of ACHE protein] |
CTD |
PMID:35833322 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Adora2a |
adenosine A2a receptor |
affects response to substance |
ISO |
ADORA2A protein affects the susceptibility to Pentylenetetrazole |
CTD |
PMID:19488739 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
increases expression multiple interactions |
EXP |
Pentylenetetrazole results in increased expression of AGER protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of AGER protein] |
CTD |
PMID:32653415 |
|
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases expression multiple interactions |
EXP |
Pentylenetetrazole results in increased expression of AKT1 mRNA Topiramate inhibits the reaction [Pentylenetetrazole results in increased expression of AKT1 mRNA] |
CTD |
PMID:34266355 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alad |
aminolevulinate dehydratase |
multiple interactions decreases activity |
ISO |
carvacryl acetate inhibits the reaction [Pentylenetetrazole results in decreased activity of ALAD protein] |
CTD |
PMID:25490531 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions increases expression |
EXP |
Dizocilpine Maleate inhibits the reaction [Pentylenetetrazole results in increased expression of APP mRNA]; Pentobarbital inhibits the reaction [Pentylenetetrazole results in increased expression of APP mRNA]; Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of APP protein] Pentylenetetrazole results in increased expression of APP mRNA; Pentylenetetrazole results in increased expression of APP protein |
CTD |
PMID:9720974 PMID:32653415 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions increases expression |
EXP |
Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of BACE1 protein] |
CTD |
PMID:32653415 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression multiple interactions decreases expression |
EXP ISO |
Pentylenetetrazole results in increased expression of BDNF mRNA; Pentylenetetrazole results in increased expression of BDNF protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of BDNF protein] daidzin inhibits the reaction [Pentylenetetrazole results in decreased expression of BDNF protein]; Diazepam inhibits the reaction [Pentylenetetrazole results in decreased expression of BDNF protein] |
CTD |
PMID:11279263 PMID:32450180 PMID:32653415 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
EXP |
Thiamine inhibits the reaction [Pentylenetetrazole results in increased expression of CASP3 protein]; Topiramate inhibits the reaction [Pentylenetetrazole results in increased expression of CASP3 mRNA] Pentylenetetrazole results in increased expression of CASP3 mRNA; Pentylenetetrazole results in increased expression of CASP3 protein |
CTD |
PMID:33771525 PMID:34266355 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
decreases expression multiple interactions decreases activity increases activity |
EXP ISO |
Pentylenetetrazole results in decreased expression of CAT protein daidzin inhibits the reaction [Pentylenetetrazole results in decreased activity of CAT protein]; Diazepam inhibits the reaction [Pentylenetetrazole results in decreased activity of CAT protein] Vitamin U inhibits the reaction [Pentylenetetrazole results in increased activity of CAT protein] |
CTD |
PMID:16122723 PMID:32450180 PMID:35833322 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
increases response to substance |
ISO |
CNR1 gene mutant form results in increased susceptibility to Pentylenetetrazole |
CTD |
PMID:26460022 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Drd1 |
dopamine receptor D1 |
multiple interactions |
ISO |
[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole; Raclopride inhibits the reaction [[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole]; SCH 23390 inhibits the reaction [[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole] |
CTD |
PMID:8103921 |
|
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
|
|
G |
Drd2 |
dopamine receptor D2 |
multiple interactions |
ISO |
[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole; Raclopride inhibits the reaction [[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole]; SCH 23390 inhibits the reaction [[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole] |
CTD |
PMID:8103921 |
|
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
ISO EXP |
Diazepam inhibits the reaction [Pentylenetetrazole results in increased expression of FOS mRNA]; Pentobarbital inhibits the reaction [Pentylenetetrazole results in increased expression of FOS mRNA] Pentylenetetrazole results in increased expression of FOS mRNA; Pentylenetetrazole results in increased expression of FOS protein delta-hexachlorocyclohexane inhibits the reaction [Pentylenetetrazole results in increased expression of FOS mRNA]; delta-hexachlorocyclohexane inhibits the reaction [Pentylenetetrazole results in increased expression of FOS protein]; Dizocilpine Maleate inhibits the reaction [Pentylenetetrazole results in increased expression of FOS protein]; Nifedipine inhibits the reaction [Pentylenetetrazole results in increased expression of FOS protein] |
CTD |
PMID:1380685 PMID:3037702 PMID:7534335 PMID:7887109 PMID:8809800 PMID:11421588 PMID:15857624 More...
|
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gabra1 |
gamma-aminobutyric acid type A receptor subunit alpha 1 |
multiple interactions |
ISO |
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Pentylenetetrazole inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] |
CTD |
PMID:14637376 |
|
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
|
|
G |
Gabra2 |
gamma-aminobutyric acid type A receptor subunit alpha 2 |
multiple interactions |
ISO |
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] |
CTD |
PMID:14637376 |
|
NCBI chr14:37,097,251...37,230,030
Ensembl chr14:37,097,279...37,228,944
|
|
G |
Gabrb2 |
gamma-aminobutyric acid type A receptor subunit beta 2 |
multiple interactions |
ISO |
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]]; Pentylenetetrazole inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] |
CTD |
PMID:14637376 |
|
NCBI chr10:26,936,592...27,156,141
Ensembl chr10:26,936,551...27,151,251
|
|
G |
Gabrg2 |
gamma-aminobutyric acid type A receptor subunit gamma 2 |
multiple interactions |
ISO |
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]]; Pentylenetetrazole inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] |
CTD |
PMID:14637376 |
|
NCBI chr10:26,374,693...26,463,937
Ensembl chr10:26,374,694...26,464,346
|
|
G |
Gad2 |
glutamate decarboxylase 2 |
increases response to substance |
ISO |
GAD2 gene mutant form results in increased susceptibility to Pentylenetetrazole |
CTD |
PMID:8954991 |
|
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
|
|
G |
Gcg |
glucagon |
decreases expression multiple interactions |
EXP |
Pentylenetetrazole results in decreased expression of GCG protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in decreased expression of GCG protein] |
CTD |
PMID:32653415 |
|
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases phosphorylation multiple interactions |
EXP |
Pentylenetetrazole results in decreased phosphorylation of GSK3B protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in decreased phosphorylation of GSK3B protein] |
CTD |
PMID:32653415 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions increases activity |
EXP |
Vitamin U inhibits the reaction [Pentylenetetrazole results in increased activity of GSR protein] |
CTD |
PMID:35833322 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression multiple interactions |
ISO |
Pentylenetetrazole results in decreased expression of HMOX1 protein daidzin inhibits the reaction [Pentylenetetrazole results in decreased expression of HMOX1 protein]; Diazepam inhibits the reaction [Pentylenetetrazole results in decreased expression of HMOX1 protein] |
CTD |
PMID:32450180 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases expression multiple interactions |
EXP |
Pentylenetetrazole results in increased expression of IGF1 protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of IGF1 protein] |
CTD |
PMID:32653415 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Kcnq2 |
potassium voltage-gated channel subfamily Q member 2 |
increases response to substance |
ISO |
KCNQ2 protein mutant form results in increased susceptibility to Pentylenetetrazole |
CTD |
PMID:26910900 |
|
NCBI chr 3:168,194,776...168,253,831
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions increases phosphorylation |
EXP |
Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased phosphorylation of MAPT protein] |
CTD |
PMID:32653415 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
increases expression multiple interactions |
EXP |
Pentylenetetrazole results in increased expression of MMP9 protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of MMP9 protein] |
CTD |
PMID:32653415 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpdz |
multiple PDZ domain crumbs cell polarity complex component |
affects response to substance |
ISO |
MPDZ protein affects the susceptibility to Pentylenetetrazole |
CTD |
PMID:14960011 |
|
NCBI chr 5:95,766,112...95,920,531
Ensembl chr 5:95,766,118...95,920,499
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions increases activity |
EXP |
Vitamin U inhibits the reaction [Pentylenetetrazole results in increased activity of MPO protein] |
CTD |
PMID:35833322 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
increases expression multiple interactions |
ISO |
Pentylenetetrazole results in increased expression of NR4A1 mRNA Dexamethasone inhibits the reaction [Pentylenetetrazole results in increased expression of NR4A1 mRNA] |
CTD |
PMID:8164692 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
increases expression |
ISO |
Pentylenetetrazole results in increased expression of NR4A2 mRNA |
CTD |
PMID:8164692 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Nrp2 |
neuropilin 2 |
affects response to substance |
ISO |
NRP2 protein affects the susceptibility to Pentylenetetrazole |
CTD |
PMID:18657176 |
|
NCBI chr 9:64,122,815...64,238,007
Ensembl chr 9:64,123,132...64,237,958
|
|
G |
Nrxn1 |
neurexin 1 |
multiple interactions |
ISO |
NRXN1 protein affects the reaction [NLG-1 results in decreased susceptibility to Pentylenetetrazole] |
CTD |
PMID:23638761 |
|
NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710
|
|
G |
Oprk1 |
opioid receptor, kappa 1 |
decreases response to substance |
ISO |
OPRK1 gene results in decreased susceptibility to Pentylenetetrazole |
CTD |
PMID:17126860 |
|
NCBI chr 5:13,860,016...13,877,823
Ensembl chr 5:13,860,021...13,877,823
|
|
G |
Pam |
peptidylglycine alpha-amidating monooxygenase |
affects response to substance |
ISO |
PAM protein affects the susceptibility to Pentylenetetrazole |
CTD |
PMID:19815072 |
|
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
|
|
G |
Pdyn |
prodynorphin |
increases cleavage decreases expression |
EXP |
Pentylenetetrazole results in increased cleavage of PDYN protein Pentylenetetrazole results in decreased expression of PDYN mRNA |
CTD |
PMID:1465197 |
|
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
|
|
G |
Rps6 |
ribosomal protein S6 |
increases expression multiple interactions |
EXP |
Pentylenetetrazole results in increased expression of RPS6 mRNA Topiramate inhibits the reaction [Pentylenetetrazole results in increased expression of RPS6 mRNA] |
CTD |
PMID:34266355 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Slc6a2 |
solute carrier family 6 member 2 |
increases response to substance |
ISO |
SLC6A2 protein results in increased susceptibility to Pentylenetetrazole |
CTD |
PMID:15911120 |
|
NCBI chr19:14,010,292...14,055,317
Ensembl chr19:14,010,386...14,050,357
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression |
EXP |
Pentylenetetrazole results in decreased expression of SOD1 protein |
CTD |
PMID:16122723 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression multiple interactions |
ISO |
Pentylenetetrazole results in increased expression of VEGFA protein daidzin inhibits the reaction [Pentylenetetrazole results in increased expression of VEGFA protein]; Diazepam inhibits the reaction [Pentylenetetrazole results in increased expression of VEGFA protein] |
CTD |
PMID:32450180 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions increases activity |
EXP |
Vitamin U inhibits the reaction [Pentylenetetrazole results in increased activity of XDH protein] |
CTD |
PMID:35833322 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|